Q32 Bio Inc.·4

Mar 27, 4:15 PM ET

Michaud Charles Jr 4

4 · Q32 Bio Inc. · Filed Mar 27, 2024

Insider Transaction Report

Form 4
Period: 2024-03-25
Transactions
  • Exercise/Conversion

    Common Stock

    2024-03-25+6,44818,046 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-03-251,0880 total
    Common Stock (1,088 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2024-03-255,3600 total
    Common Stock (5,360 underlying)
Footnotes (2)
  • [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
  • [F2]The vesting of these RSUs has been accelerated such that the RSUs vested in full on March 25, 2024, immediately prior to the Effective Time as defined in that certain Agreement and Plan of Merger by and among the Issuer, Kenobi Merger Sub, Inc. and Q32 Bio Inc. dated November 16, 2023.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4